Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
29 March 2024
m 01:11 | Mantle cell lymphoma diffhist +115 Jwarner talk contribs →Regimen variant #2, alternating {{#subobject:baugja|Variant=1}} |
27 March 2024
m 11:29 | Peripheral T-cell lymphoma diffhist -1 Jwarner talk contribs →Supportive therapy |
m 00:42 | Testicular cancer diffhist 0 Warner-admin talk contribs Text replacement - "cycles, given" to "cycles; given" |
|
m 00:27 | Acute promyelocytic leukemia 2 changes history -40 [Warner-admin (2×)] | |||
m |
|
00:27 (cur | prev) -32 Warner-admin talk contribs Text replacement - "One course of up to 90 days" to "Up to 90-day course" | |||
m |
|
00:27 (cur | prev) -8 Warner-admin talk contribs Text replacement - "One course of up to 60 days" to "Up to 60-day course" |
26 March 2024
m 11:29 | Colon cancer - historical diffhist 0 Warner-admin talk contribs Text replacement - "14-day cycle for 12 cycles, to start within 10 weeks of surgery" to "14-day cycle for 12 cycles; to start within 10 weeks of surgery" |
m 01:35 | Acute promyelocytic leukemia diffhist +5 Jwarner talk contribs →Targeted therapy |
m 00:31 | Breast cancer diffhist -19 Jwarner talk contribs →Metastatic disease, subsequent lines of chemotherapy |
25 March 2024
m 01:07 | Gestational trophoblastic neoplasia diffhist +43 Jwarner talk contribs →Low-risk disease, all lines of therapy |
24 March 2024
m 20:00 | Diffuse large B-cell lymphoma diffhist -29 Jwarner talk contribs |
m 17:59 | Classical Hodgkin lymphoma - historical diffhist +125 Jwarner talk contribs |
m 17:00 | Small cell lung cancer diffhist +24 Jwarner talk contribs |
|
m 12:03 | Urothelial carcinoma 2 changes history -50 [Jwarner (2×)] | |||
m |
|
12:03 (cur | prev) +1 Jwarner talk contribs →Regimen variant #2, AUC 4.5/1000, indefinite {{#subobject:5f0in7|Variant=1}} | |||
m |
|
12:02 (cur | prev) -51 Jwarner talk contribs →Chemotherapy |
m 11:37 | Non-small cell lung cancer - historical diffhist +2,765 Jwarner talk contribs →MVP & RT {{#subobject:10d15d|Regimen=1}} |
m 02:17 | Breast cancer diffhist +150 Jwarner talk contribs →Regimen variant #2 {{#subobject:bf8gub|Variant=1}} |
m 00:23 | Head and neck cancer diffhist -13 Jwarner talk contribs |
23 March 2024
|
m 12:25 | B-cell acute lymphoblastic leukemia 3 changes history -54 [Jwarner (3×)] | |||
m |
|
12:25 (cur | prev) +2,810 Jwarner talk contribs →Relapsed or refractory | |||
m |
|
12:25 (cur | prev) -2,834 Jwarner talk contribs →Cytarabine & Mitoxantrone (MC) {{#subobject:6237f0|Regimen=1}} | |||
m |
|
12:25 (cur | prev) -30 Jwarner talk contribs →Inotuzumab ozogamicin monotherapy {{#subobject:d90806|Regimen=1}} |
m 12:13 | Diffuse large B-cell lymphoma diffhist -27 Jwarner talk contribs |
|
m 11:28 | Mantle cell lymphoma 5 changes history +367 [Jwarner (5×)] | |||
m |
|
11:28 (cur | prev) +34 Jwarner talk contribs →maxi-R-CHOP/R-HiDAC {{#subobject:360f9d|Regimen=1}} | |||
m |
|
11:02 (cur | prev) +12 Jwarner talk contribs | |||
m |
|
11:01 (cur | prev) +2 Jwarner talk contribs →R-MACLO/R-IVAM {{#subobject:51391f|Regimen=1}} | |||
m |
|
11:01 (cur | prev) +8,730 Jwarner talk contribs →R-DHAC {{#subobject:ed2a61|Regimen=1}} | |||
m |
|
10:59 (cur | prev) -8,411 Jwarner talk contribs →R-MACLO/R-IVAM {{#subobject:51391f|Regimen=1}} |
m 11:17 | Small cell lung cancer diffhist 0 Jwarner talk contribs |
|
m 11:16 | Small cell lung cancer - historical 2 changes history -44 [Jwarner (2×)] | |||
m |
|
11:16 (cur | prev) +5,168 Jwarner talk contribs →CDE {{#subobject:344f89|Regimen=1}} | |||
m |
|
11:11 (cur | prev) -5,212 Jwarner talk contribs →ACE {{#subobject:9fbf31|Regimen=1}} |
|
m 10:47 | Non-small cell lung cancer - historical 3 changes history +186 [Jwarner (3×)] | |||
m |
|
10:47 (cur | prev) +91 Jwarner talk contribs →VIP (Vinblastine) {{#subobject:e6f7b9|Regimen=1}} | |||
m |
|
01:57 (cur | prev) +2,443 Jwarner talk contribs →Cisplatin monotherapy {{#subobject:a0eb49|Regimen=1}} | |||
m |
|
01:56 (cur | prev) -2,348 Jwarner talk contribs →CAP (Platinol) {{#subobject:379e5f|Regimen=1}} |
m 01:55 | Ovarian cancer - historical diffhist +135 Jwarner talk contribs |
m 01:52 | Urothelial carcinoma diffhist -2,238 Jwarner talk contribs →Locally advanced or metastatic disease, first-line, platinum-eligible |
m 00:28 | Acute myeloid leukemia diffhist +123 Jwarner talk contribs |
22 March 2024
m 17:03 | Acute myeloid leukemia diffhist -12 Jwarner talk contribs |
m 16:27 | Diffuse large B-cell lymphoma diffhist +45 Jwarner talk contribs →R-DHAOx {{#subobject:0d0c67|Regimen=1}} |
|
m 11:33 | Bladder cancer 2 changes history -175 [Jwarner (2×)] | |||
m |
|
11:33 (cur | prev) 0 Jwarner talk contribs →Gemcitabine & RT {{#subobject:91c0ea|Regimen=1}} | |||
m |
|
11:03 (cur | prev) -175 Jwarner talk contribs |